-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $86 at Stifel
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $106 at Barclays
-
-
-
-
-
-
-
Wolfe Research on Ionis Pharmaceuticals (IONS): new Tryngolza pricing likely to ‘squeeze’ Arrowhead’s rival drug
-
-
-
-
-
-
-
RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
Biogen (BIIB): High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $99 at TD Cowen, Top Pick
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $90 at Oppenheimer
-
413,534 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

